Lumos Pharma, Inc. (LUMO)

Lumos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	38	25	30	58	296	-
Market Cap Growth	20.06%	-16.77%	-47.79%	-80.45%	-	-
Enterprise Value	24	-17	-43	-42	191	-
Last Close Price	4.34	3.18	3.61	6.93	35.71	-
PS Ratio	16.06	12.27	19.85	251.81	1763.62	-
PB Ratio	7.64	0.92	0.51	0.65	2.54	-
P/TBV Ratio	6.40	0.92	0.51	0.65	2.54	-
EV/Sales Ratio	10.97	-	-	-	1138.59	-
Debt / Equity Ratio	0.04	0.02	0.00	0.01	0.00	0.09
Asset Turnover	0.07	0.04	0.02	0.00	0.00	-
Quick Ratio	2.10	5.16	10.07	18.51	19.34	3.95
Current Ratio	2.66	5.69	10.73	19.43	19.88	4.01
Return on Equity (ROE)	-172.83%	-78.34%	-41.82%	-29.61%	-9.39%	-109.98%
Return on Assets (ROA)	-69.64%	-40.53%	-23.20%	-17.09%	-24.43%	-61.78%
Return on Capital (ROIC)	-111.17%	-52.18%	-26.82%	-18.98%	-27.10%	-68.06%
Earnings Yield	-93.02%	-135.23%	-102.72%	-52.54%	-1.91%	-
FCF Yield	-84.38%	-123.55%	-88.11%	-51.24%	-7.77%	-
Buyback Yield / Dilution	0.71%	2.73%	-0.47%	-22.97%	11.44%	25.58%
Total Shareholder Return	0.71%	2.73%	-0.47%	-22.97%	11.44%	25.58%

Source: S&P Capital IQ. Standard template. Financial Sources.